Cingulate Inc (CING)
4.23
+0.01
(+0.24%)
USD |
NASDAQ |
Nov 15, 16:00
4.21
-0.02
(-0.47%)
After-Hours: 18:28
Cingulate Cash and Short Term Investments (Quarterly): 10.04M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 10.04M |
| June 30, 2024 | 0.3809M |
| March 31, 2024 | 1.114M |
| December 31, 2023 | 0.0524M |
| September 30, 2023 | 1.986M |
| June 30, 2023 | 0.3498M |
| March 31, 2023 | 1.739M |
| December 31, 2022 | 5.356M |
| Date | Value |
|---|---|
| September 30, 2022 | 9.796M |
| June 30, 2022 | 8.196M |
| March 31, 2022 | 12.62M |
| December 31, 2021 | 16.49M |
| September 30, 2021 | 1.916M |
| June 30, 2021 | 1.045M |
| December 31, 2020 | 1.199M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
0.0524M
Minimum
Dec 2023
16.49M
Maximum
Dec 2021
4.819M
Average
1.916M
Median
Sep 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| United Therapeutics Corp | 3.326B |
| Tonix Pharmaceuticals Holding Corp | 4.156M |
| Geovax Labs Inc | 1.562M |
| NovaBay Pharmaceuticals Inc | 0.776M |
| Palatin Technologies Inc | 9.527M |